-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
BriaCell Therapeutics Corp. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2021 to Q2 2023.
- BriaCell Therapeutics Corp. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending July 31, 2023 was $45.2K, a 6.64% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)